Güneş Esendağli (Gunes Esendagli)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Cell Cycle Arrest

Transcription Factor

Gold Nanoparticles

Endoplasmic Reticulum Stress

Top Venues

European journal of immunology

Molecular pharmaceutics

Immunological investigations

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Mubaida Parveen, Beren Karaosmanoglu, Ceren Sucularli, Aysegul Uner, Ekim Z Taskiran, Güneş Esendağli
Acquired immune resistance is associated with interferon signature and modulation of KLF6/c-MYB transcription factors in myeloid leukemia. European journal of immunology (2024)
Sibel Goksen, Gamze Varan, Erem Bilensoy, Güneş Esendağli
Folate Receptor β (FRβ) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles' Biodistribution in Cancer. Molecular pharmaceutics (2024)
Sibel Goksen, Gamze Varan, Erem Bilensoy, Güneş Esendağli
Folate Receptor β (FRβ) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles' Biodistribution in Cancer. Molecular pharmaceutics 21 (9) (2024)
Mubaida Parveen, Beren Karaosmanoglu, Ceren Sucularli, Aysegul Uner, Ekim Z Taskiran, Güneş Esendağli
Acquired immune resistance is associated with interferon signature and modulation of KLF6/c-MYB transcription factors in myeloid leukemia. European journal of immunology 54 (5) (2024)
Mubaida Parveen, Beren Karaosmanoglu, Ceren Sucularli, Aysegul Uner, Ekim Z Taskiran, Güneş Esendağli
Acquired immune resistance is associated with interferon signature and modulation of KLF6/c-MYB transcription factors in myeloid leukemia. European journal of immunology (2024)
Utku Horzum, Hamdullah Yanik, Ekim Z Taskiran, Güneş Esendağli
Effector Th1 cells under PD-1 and CTLA-4 checkpoint blockade abrogate the upregulation of multiple inhibitory receptors and by-pass exhaustion. Immunology 167 (4) (2022)
Neşe Ünver, Digdem Y Ermis, Bahar Zehra Camurdanoglu Weber, Güneş Esendağli
Transcriptional splice variants of CD40 and its prognostic value in breast cancer. Turkish journal of biology = Turk biyoloji dergisi 44 (2) (2020)
Ece Tavukcuoglu, Utku Horzum, Kerim B Yilmaz, Güneş Esendağli
PD-L2+ wound zone macrophage-like cells display M1/M2-mixed activation and restrain the effector Th1 responses. Immunology and cell biology 98 (2) (2020)
Ece Tavukcuoglu, Utku Horzum, Hamdullah Yanik, Aysegul Uner, Digdem Yoyen-Ermis, Safa K Nural, Busra Aydin, Cenk Sokmensuer, Derya Karakoc, Kerim Bora Yilmaz, Erhan Hamaloglu, Güneş Esendağli
Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer. European journal of immunology 50 (12) (2020)
Utku Horzum, Digdem Yoyen-Ermis, Ekim Z Taskiran, Kerim Bora Yilmaz, Erhan Hamaloglu, Derya Karakoc, Güneş Esendağli
CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer. Cancer immunology, immunotherapy : CII 70 (1) (2020)
Murat Sevmis, Digdem Yoyen-Ermis, Cisel Aydin, Elif Bilgic, Petek Korkusuz, Aysegul Uner, Erhan Hamaloglu, Güneş Esendağli, Derya Karakoc
Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis. Immunological investigations 46 (7) (2018)
Digdem Yoyen-Ermis, Kivilcim Ozturk-Atar, M Alper Kursunel, Cisel Aydin, Didem Ozkazanc, Mustafa Ulvi Gurbuz, Aysegul Uner, Metin Tulu, Sema Calis, Güneş Esendağli
Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody. Molecular pharmaceutics 15 (4) (2018)